Orion Infusion Limited announcements
236 Dhaka Stock Exchange announcements for Orion Infusion Limited (ORIONINFU) since 2007: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2009 (19).
- Orion Laboratories Limited, one of the corporate Sponsors of the company, has reported its intention to sell 3,00,000 sh
Orion Laboratories Limited, one of the corporate Sponsors of the company, has reported its intention to sell 3,00,000 shares out of its total holdings of 7,43,000 shares of the company (In the Block Market) at prevailing market price through Stock Exchange within next 30 working days.
- The company will be placed in "A" category from existing "Z" category with effect from 30.12.09 as the company reported
The company will be placed in "A" category from existing "Z" category with effect from 30.12.09 as the company reported disbursement of cash dividend @ 12.50% for the year 2008-2009.
- Normal trading of the shares of the company will resume on 22.11.09 following the starting date of Book-Closure.
Normal trading of the shares of the company will resume on 22.11.09 following the starting date of Book-Closure.
- Trading of the shares of the company will remain suspended on 19.11.09, as Book Closure will start from 22.11.09.
Trading of the shares of the company will remain suspended on 19.11.09, as Book Closure will start from 22.11.09.
- Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be
Trading of the shares of the company will be allowed only in the Spot Market and Block/Odd lot transactions will also be settled as per Spot settlement cycle with cum benefit from 09.11.09 to 18.11.09. Trading of the shares of the company will remain suspended on 19.11.09 as Book Closure will start from 22.11.09.
- There will be no price limit on the trading of the shares of the company today (08.11.09) following its corporate declar
There will be no price limit on the trading of the shares of the company today (08.11.09) following its corporate declaration.
- (continuation of news of Orion Infusion Ltd.): The company has also informed that the Board has accepted the report on v
(continuation of news of Orion Infusion Ltd.): The company has also informed that the Board has accepted the report on valuation of the company's Lands and Buildings and other constructions as of 30 June 2009 issued by Ata Khan and Co., Chartered Accountants and Valuers, showing aggregate depreciated current cost thereof at Tk. 249,573,749 and resulting in a revaluation surplus aggregating Tk. 166,981,322 for incorporation thereof in its financial statements for the year ended 30 June 2009.
The first part of this announcement is missing from the archive. - The Board of Directors has recommended cash dividend @ 12.50% for the year 2008-2009. Date of AGM: 10.12.09, Time: 9:00
The Board of Directors has recommended cash dividend @ 12.50% for the year 2008-2009. Date of AGM: 10.12.09, Time: 9:00 AM, Venue: Bangabandhu International Conference Centre, Agargaon, Sher-E-Bangla Nagar, Dhaka. Book Closure: 22.11.09 to 10.12.09. The company has also reported Earning Per share (EPS) of Tk. 12.87, Net Asset Value (NAV) per share of Tk. 99.39 and Net Operating Cash Flow per share of Tk. 31.44 for the year ended on June 30, 2009. (continue)
- (Continuation news of Orion Infusion Ltd.): This has been a problem over last some months which we have been regularly i
(Continuation news of Orion Infusion Ltd.): This has been a problem over last some months which we have been regularly informing this matter to you. We are afraid that this unusual price increase would adversely affect the goodwill of the company".
The first part of this announcement is missing from the archive. - In response to a DSE query dated 05.10.09, the company has informed that "at the moment there is no undisclosed material
In response to a DSE query dated 05.10.09, the company has informed that "at the moment there is no undisclosed material decision/information relating to the operation or profitability to Orion Infusion Limited which may affect the price hike of the Company's share. Nor even there is any additional disclosure pertinent to company's Member of the Board, any of its subsidiaries or Group that might have any impact on the trade of the shares of the company. The management of the company is also worried about this unusual increase and would like to confirm you that there is no substantial sales increase happening in the company over last some months which may affect the profitability of the company. (Continue)
- In response to DSE query dated 12.08.09, the company has informed that there is no undisclosed price sensitive informati
In response to DSE query dated 12.08.09, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- (Continuation news of Orion Infusion Ltd.)This has been a problem over last some months which we have been regularly inf
(Continuation news of Orion Infusion Ltd.)This has been a problem over last some months which we have been regularly informing this matter to you. We are afraid that this unusual price increase would adversely affect the goodwill of the company".
The first part of this announcement is missing from the archive. - In response to a DSE query the company has informed that "at the moment there is no undisclosed material decision/inform
In response to a DSE query the company has informed that "at the moment there is no undisclosed material decision/information relating to the operation or profitability to Orion Infusion Limited which may affect the price hike of the Company's share. Nor even there is any additional disclosure pertinent to company's Member of the Board, any of its subsidiaries or Group that might have any impact on the trade of the shares of the company.The management of the company is also worried about this unusual increase and would like to confirm you that there is no substantial sales increase happening in the company over last some months which may affect the profitability of the company.(Continue)
- Trading of the shares of the company will remain halted for market enquiry.
Trading of the shares of the company will remain halted for market enquiry.
- In response to a DSE query, the company has informed that at the moment there is no undisclosed material information of
In response to a DSE query, the company has informed that at the moment there is no undisclosed material information of the company which may have impact on the price of the company's shares. The management of the company is also concerned about this price hike and would like to confirm that there is no unusual sales increase happening in the company over last few months which may affect the profitability of the company.
- The company will not be upgraded (shall remain in Z Category) this year, as the company could not submit dividend distri
The company will not be upgraded (shall remain in Z Category) this year, as the company could not submit dividend distribution compliance report within the stipulated time as per securities laws.
- In response to a DSE query dated 16.02.09, the company has informed that there is no undisclosed price sensitive informa
In response to a DSE query dated 16.02.09, the company has informed that there is no undisclosed price sensitive information of the company for recent unusual price hike.
- As per un-audited half yearly accounts as on 31.12.08, the Company has reported net profit of Tk. 15.73 m. as against la
As per un-audited half yearly accounts as on 31.12.08, the Company has reported net profit of Tk. 15.73 m. as against last year's half yearly of Tk. 7.58 m. Accumulated loss of the Company was Tk. (178.69) m. as on 31.12.08.
- In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Com
In response to a DSE query, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.